These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 16512166)

  • 21. [Epizootic situation and measures for control of wild animals' rabies in Republic of Bashkortostan].
    Ianbarisova SR; Khismatullina NA; Sharafutdinova RS
    Zh Mikrobiol Epidemiol Immunobiol; 2008; (4):98-100. PubMed ID: 18819417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of an oral vaccinia-rabies glycoprotein recombinant vaccine in controlling epidemic raccoon rabies in New Jersey.
    Roscoe DE; Holste WC; Sorhage FE; Campbell C; Niezgoda M; Buchannan R; Diehl D; Niu HS; Rupprecht CE
    J Wildl Dis; 1998 Oct; 34(4):752-63. PubMed ID: 9813845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and immunogenicity of Ontario Rabies Vaccine Bait (ONRAB) in the first us field trial in raccoons (Procyon lotor).
    Slate D; Chipman RB; Algeo TP; Mills SA; Nelson KM; Croson CK; Dubovi EJ; Vercauteren K; Renshaw RW; Atwood T; Johnson S; Rupprecht CE
    J Wildl Dis; 2014 Jul; 50(3):582-95. PubMed ID: 24807178
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Baldi M; Hernández-Mora G; Jimenez C; Hutter SE; Alfaro A; Walzer C
    Vector Borne Zoonotic Dis; 2019 Dec; 19(12):889-895. PubMed ID: 31407956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rabies postexposure prophylaxis--Connecticut, 1990-1994.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Mar; 45(11):232-4. PubMed ID: 8606682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Animal rabies in Massachusetts, 1985-2006.
    Wang X; Werner BG; Konomi R; Hennigan D; Fadden D; Caten E; Soliva S; DeMaria A
    J Wildl Dis; 2009 Apr; 45(2):375-87. PubMed ID: 19395747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. First North American field release of a vaccinia-rabies glycoprotein recombinant virus.
    Hanlon CA; Niezgoda M; Hamir AN; Schumacher C; Koprowski H; Rupprecht CE
    J Wildl Dis; 1998 Apr; 34(2):228-39. PubMed ID: 9577769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time series analysis of the impact of oral vaccination on raccoon rabies in West Virginia, 1990-2007.
    Ma X; Blanton JD; Rathbun SL; Recuenco S; Rupprecht CE
    Vector Borne Zoonotic Dis; 2010 Oct; 10(8):801-9. PubMed ID: 20020812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral rabies vaccine contact by raccoons and nontarget species in a field trial in Florida.
    Olson CA; Werner PA
    J Wildl Dis; 1999 Oct; 35(4):687-95. PubMed ID: 10574527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A spatial model to forecast raccoon rabies emergence.
    Recuenco S; Blanton JD; Rupprecht CE
    Vector Borne Zoonotic Dis; 2012 Feb; 12(2):126-37. PubMed ID: 21995266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunogenicity and efficacy of two rabies vaccines in wild-caught, captive raccoons.
    Brown LJ; Rosatte RC; Fehlner-Gardiner C; Knowles MK; Bachmann P; Davies JC; Wandeler A; Sobey K; Donovan D
    J Wildl Dis; 2011 Jan; 47(1):182-94. PubMed ID: 21270007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proposed field evaluation of a rabies recombinant vaccine for raccoons (Procyon lotor): site selection, target species characteristics, and placebo baiting trials.
    Hanlon CL; Hayes DE; Hamir AN; Snyder DE; Jenkins S; Hable CP; Rupprecht CE
    J Wildl Dis; 1989 Oct; 25(4):555-67. PubMed ID: 2810556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Economics of a Successful Raccoon Rabies Elimination Program on Long Island, New York.
    Elser JL; Bigler LL; Anderson AM; Maki JL; Lein DH; Shwiff SA
    PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005062. PubMed ID: 27935946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Geography but not alternative host species explain the spread of raccoon rabies virus in Vermont.
    Nadin-Davis SA; Fu Q; Trewby H; Biek R; Johnson RH; Real L
    Epidemiol Infect; 2018 Nov; 146(15):1977-1986. PubMed ID: 29941066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Benefits and costs of using an orally absorbed vaccine to control rabies in raccoons.
    Uhaa IJ; Dato VM; Sorhage FE; Beckley JW; Roscoe DE; Gorsky RD; Fishbein DB
    J Am Vet Med Assoc; 1992 Dec; 201(12):1873-82. PubMed ID: 1483905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exposure time of oral rabies vaccine baits relative to baiting density and raccoon population density.
    Blackwell BF; Seamans TW; White RJ; Patton ZJ; Bush RM; Cepek JD
    J Wildl Dis; 2004 Apr; 40(2):222-9. PubMed ID: 15362821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors for human exposure to raccoon rabies during an epizootic in Connecticut.
    Bretsky PM; Wilson ML
    Vector Borne Zoonotic Dis; 2001; 1(3):211-7. PubMed ID: 12653149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rabies epizootics among raccoons vary along a North-South gradient in the Eastern United States.
    Childs JE; Curns AT; Dey ME; Real AL; Rupprecht CE; Krebs JW
    Vector Borne Zoonotic Dis; 2001; 1(4):253-67. PubMed ID: 12653126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of a vaccinia-rabies glycoprotein recombinant virus vaccine in raccoons (Procyon lotor).
    Rupprecht CE; Hamir AN; Johnston DH; Koprowski H
    Rev Infect Dis; 1988; 10 Suppl 4():S803-9. PubMed ID: 3206091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surveillance and epidemiologic mapping of monoclonal antibody-defined rabies variants in Florida.
    Smith JS; Yager PA; Bigler WJ; Hartwig EC
    J Wildl Dis; 1990 Oct; 26(4):473-85. PubMed ID: 2250324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.